Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Resteghini

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cancer|February 8, 2020
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of lifeLaura D Locati, Donata Galbiati, Giuseppina Calareso, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumoursPaolo Bossi, Ester Orlandi, Carlo Resteghini, et al.
Oral Oncology|August 9, 2025
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disordersCristina Gurizzan, Armando G Licata, Luigi Lorini, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2020
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glandsStefano Cavalieri, Luigi Mariani, Vincent Vander Poorten, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumoursCarlo Resteghini, Paolo Castelnuovo, Piero Nicolai, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Oral Oncology|May 26, 2025
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2Paolo Rondi, Davide Mattavelli, Vittorio Rampinelli, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
European Journal of Radiology|April 21, 2026
Radiological-pathological correlation of Head and Neck Cancer International Group (HNCIG) criteria for extranodal extension across imaging modalities: A retrospective cohort studyCaterina Giannitto, Giulia Mari, Sebastiano Pindilli, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer|February 8, 2020
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of lifeLaura D Locati, Donata Galbiati, Giuseppina Calareso, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumoursPaolo Bossi, Ester Orlandi, Carlo Resteghini, et al.
Oral Oncology|August 9, 2025
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disordersCristina Gurizzan, Armando G Licata, Luigi Lorini, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2020
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glandsStefano Cavalieri, Luigi Mariani, Vincent Vander Poorten, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumoursCarlo Resteghini, Paolo Castelnuovo, Piero Nicolai, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Oral Oncology|May 26, 2025
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2Paolo Rondi, Davide Mattavelli, Vittorio Rampinelli, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
European Journal of Radiology|April 21, 2026
Radiological-pathological correlation of Head and Neck Cancer International Group (HNCIG) criteria for extranodal extension across imaging modalities: A retrospective cohort studyCaterina Giannitto, Giulia Mari, Sebastiano Pindilli, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
Pageof 7